While PDAC is characterized by KRAS-dependent signaling activation and loss of tumor suppressor function through TP53 mutations, ITPN shows enrichment of alterations affecting growth factor signaling pathways through FGFR2 fusions and PI3K pathway activation. Here, PIK3CA is linked to neoplasm.